Currently out of the existing stock ratings of Michael Freeman, 17 are a BUY (85%), 3 are a HOLD (15%).
Analyst Michael Freeman, currently employed at RAYMOND JAMES, has had 34.38% of price targets met with an average potential upside of 20.17%, reached in 37 days on average.
Michael Freeman has documented 39 price targets and ratings displayed on 7 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on TECX, Tectonic Therapeutic at 25-May-2026.
Analyst best performing recommendations are on WVE (WAVE LIFE SCIENCES LTD).
The best stock recommendation documented was for WVE (WAVE LIFE SCIENCES LTD) on 12/8/2025. The price target of $21 was fulfilled within 1 day with a profit of $2.48 (13.39%), with a performance score of 133.91.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 09-Dec-2025
$9
$0.78 (9.49%)
$7
10 days ago
(11-Nov-2026)
5/10 (50%)
$0.65 (7.78%)
148
Hold Since 01-Sep-2022
$9
$4.24 (89.08%)
$10
6 months 25 days ago
(27-Apr-2026)
13/26 (50%)
$3.42 (61.29%)
164
Hold Since 25-Jul-2024
$8
$3.24 (68.07%)
$7
10 months 14 days ago
(07-Jan-2026)
1/2 (50%)
$0.1 (1.27%)
53
Hold Since 10-Jul-2024
$8
1 years 6 months 16 days ago
(05-May-2025)
2/2 (100%)
$3.07 (62.27%)
86
Hold Since 22-Jan-2021
$3
2 years 3 months 19 days ago
(02-Aug-2024)
11/13 (84.62%)
$-2.63 (-46.71%)
164
Which stock is Michael Freeman most bullish on?
What Year was the first public recommendation made by Michael Freeman?